Brokerage Firm Rating on Allergan plc. (AGN)

Allergan plc. (AGN) : 9 brokerage houses believe that Allergan plc. (AGN) is a Strong Buy at current levels. 3 Analyst considers the fundamentals to be worthy of a Buy recommendation. 4 analysts believe that the current prices are in a balance with the stocks fundamentals, hence they propose Hold on Allergan plc. (AGN). Zacks Investment Research suggests a Hold with a rank of 3.The median of all the 16 Wall Street Analysts endorse the stock as a Buy with a rating of 1.66.

Allergan plc. (AGN) : Currently there are 11 street experts covering Allergan plc. (AGN) stock. The most bullish and bearish price target for the stock is $400 and $236 respectively for the short term. The average price target of all the analysts comes to $290. The estimated standard deviation from the target is $42.64.


For the current week, the company shares have a recommendation consensus of Buy. Allergan plc. (NYSE:AGN): During Thursdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $252.24 and $252.11 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $255.88. The buying momentum continued till the end and the stock did not give up its gains. It closed at $253.02, notching a gain of 0.33% for the day. The total traded volume was 2,881,263 . The stock had closed at $252.18 on the previous day.

In a related news, Hilado Maria Teresa, CFO of Allergan Plc had purchased 661 shares on June 2, 2016 in a transaction. The price per share was $241.57 and the total amount of the disclosed transaction was $159,678.The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing. This information is based on open market transaction at the market prices.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.